Cardiovascular medications are the #1
most prescribed drugs in the world.

PGxCardio™ is a 50-gene pharmacogenomics test report
that predicts how a patient will respond to 62 different
cardiac drug therapies based on their genetic background.

Sample Report
Information Sheet

Cardiovascular medications
are the #1 most prescribed
drugs in the world.

PGxCardio™ is a 50-gene pharmacogenomics
test report that predicts how a patient will
respond to 62 differentcardiac drug therapies
based on their genetic background.

Sample Report
Information Sheet
PGcardio_Logo-e1534181379700 PGxCardio™

Improve cardiovascular treatment from diagnosis to outcome

Because cardiovascular medications are one of the most frequently-prescribed drug classes that leads to medication errors, the odds ratio that a cardiovascular medication can lead to an adverse drug event is 2.4x that of other drug class medications1

Common cardiovascular categories and indications

Cardiomyopathies-1-150x150 PGxCardio™

Cardiomyopathies

Hypertrophic Cardiomyopathy (HCM)
Dilated Cardiomyopathy (DCM)
Arrhythmogenic Cardiomyopathy (ARVC/D)
Left Ventricular Noncompaction (LVNC)
Restrictive Cardiomyopathy (RCM)

Arrhythmias-150x150 PGxCardio™

Arrhythmias and
Channelopathies

Long QT Syndrome
Short QT Syndrome
Brugada/J Wave Syndrome
Catecholaminergic Polymorphic Ventricular
Tachycardia (CPVT)

Atheroscierotic-150x150 PGxCardio™

Atherosclerotic
Disorders

Coronary Artery Disease
Familial Hypercholesterolemia
Familial Hypertriglyceridemia
Other Hyperlipidemias and Dyslipidemias

Drug classes covered

  • Angiotensin-Converting Enzyme (ACE) Inhibitors
  • Angiotensin II Receptor Blockers (ARBs)
  • Antianginal Agents
  • Antiarrhythmic Agents
  • Anticoagulants
  • Antilipemic Agents (statins)
  • Antiplatelets
  • Beta Blockers
  • Calcium Channel Blockers
  • Diuretics
  • Phosphodiesterase Inhibitors
  • Vasodilators

Drug classes covered

  • Angiotensin-Converting Enzyme (ACE) Inhibitors
  • Angiotensin II Receptor Blockers (ARBs)
  • Antianginal Agents
  • Antiarrhythmic Agents
  • Anticoagulants
  • Antilipemic Agents (statins)
  • Antiplatelets
  • Beta Blockers
  • Calcium Channel Blockers
  • Diuretics
  • Phosphodiesterase Inhibitors
  • Vasodilators

Proven utility: Be proactive and preventative

Most  preventable medication related hospital ER visits are due to antithrombosis, antidiabetic, or NSAIDs.

Howard RL, Avery AJ, Slavenburg S, et al. Which drugs cause preventable admissions to hospital? A systematic review. Br J Clin Pharmacol. 2006;63(2):136–147

Two-thirds of all medication-related  admissions to the hospital involved  antithrombotic and antidiabetic  medications, almost always by  unintentional overdose.

Budnitz DS, Lovegrove MC, Shehab N, Richards CL. Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med. 2011;365(21):2002–2012.

Aging decreases first-pass clearance in  the liver, and a number of commonly  prescribed medications (e.g., warfarin  [Coumadin], benzodiazepines, opiates)  require much lower doses in older adults.

Pretorius RW et al. Am Fam Physician. 2013 Mar 1;87(5):331-336.

Patients with ADEs incur greater charges. The charges attributable to an ambulatory ADE are a significant cost to the health care delivery system on the order of $8 billion annually.

Burton MM, Hope C, Murray MD, Hui S, Overhage JM. The cost of adverse drug events in ambulatory care. AMIA Annu Symp Proc. October 11, 2007:90-93.

Actionable Reports

PGxCardio™ testing provides patient-centric and easy-to-understand reports

View Sample Report
PGxCardio_Thumnail PGxCardio™

Clear, Color-Coded Results

Results are delivered in an easy to manage report, providing the relevant information to make more informed treatment decisions

PGxCardio™ complements Admera Health’s two other products in its cardiovascular test portfolio

AtheroGxOne_logo PGxCardio™

A comprehensive 84-gene
genetictest to aid in the risk
assessment and diagnosis of early
atherosclerosis/dyslipidemias

Learn more
CardioGxOne_logo PGxCardio™

A comprehensive 213-gene genetic
test that provides expert analysis
on a broad scope of conditions
(e.g. cardiomyopathies, aortic syndromes,
channelopathies & arrythmias, and many more)

Learn more

PGxCardio™ complements Admera Health’s two other products in its cardiovascular test portfolio

AtheroGxOne_logo PGxCardio™

A comprehensive 84-gene genetic
test to aid in the risk assessment
and diagnosis of early
atherosclerosis/dyslipidemias

Learn more
CardioGxOne_logo PGxCardio™

A comprehensive 213-gene genetic test that provides expert analysis on a broad scope of conditions (e.g. cardiomyopathies, aortic syndromes, channelopathies & arrythmias, and many more)

Learn more

1. LaPointe NM, Jollis JG. Medication errors in hospitalized cardiovascular patients. Arch Intern Med. 2003;163:1461 AND Lesar TS, Lomaestro BM, Pohl H. Medication-prescribing errors in a teaching hospital: A nine year experience. Arch Intern Med. 1997;157:1569–76.

1. LaPointe NM, Jollis JG. Medication errors in hospitalized cardiovascular patients. Arch Intern Med. 2003;163:1461 AND Lesar TS, Lomaestro BM, Pohl H. Medication-prescribing errors in a teaching hospital: A nine year experience. Arch Intern Med. 1997;157:1569–76.